Ben Goldacre writes that big pharma’s history of publishing favorable data – like flipping a coin and hiding the result when it comes up heads – has in fact been outlawed but has gone unpunished.
Ben Goldacre writes that big pharma’s history of publishing favorable data – like flipping a coin and hiding the result when it comes up heads – has in fact been outlawed but has gone unpunished.